Palù G, Parolin C, Takeuchi Y, Pizzato M
Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, Italy.
Rev Med Virol. 2000 May-Jun;10(3):185-202. doi: 10.1002/(sici)1099-1654(200005/06)10:3<185::aid-rmv285>3.0.co;2-8.
Retroviral vectors have become a standard tool for gene transfer technology. Compared with other gene transfer systems, retroviral vectors have several advantages, including their ability to transduce a variety of cell types, to integrate efficiently into the genomic DNA of the recipient cells and to express the transduced gene at high levels. The relatively well understood biology of retroviruses has made possible the development of packaging cell lines which provide in trans all the viral proteins required for viral particle formation. The design of different types of packaging cells has evolved to reduce the possibility of helper virus production. The host range of retroviruses has been expanded by pseudotyping the vectors with heterologous viral glycoproteins and receptor-specific ligands. The development of lentivirus vectors has allowed efficient gene transfer to quiescent cells. This review describes different strategies adopted for developing vectors to be used in gene therapy applications.
逆转录病毒载体已成为基因转移技术的标准工具。与其他基因转移系统相比,逆转录病毒载体具有多个优点,包括能够转导多种细胞类型、有效整合到受体细胞的基因组DNA中以及高水平表达转导基因。逆转录病毒相对为人熟知的生物学特性使得包装细胞系得以开发,这些细胞系可在反式作用下提供病毒颗粒形成所需的所有病毒蛋白。不同类型包装细胞的设计不断演变,以降低产生辅助病毒的可能性。通过用异源病毒糖蛋白和受体特异性配体对载体进行假型化,扩大了逆转录病毒的宿主范围。慢病毒载体的开发使得能够有效地将基因转移到静止细胞中。本综述描述了为开发用于基因治疗应用的载体而采用的不同策略。